Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.

Yingchi Yang(Capital Medical University), Zhongtao Zhang(National Clinical Research Center for Digestive Diseases), Dong Wang(Capital Medical University), Jun Zhang(National Clinical Research Center for Digestive Diseases), Guanzhen Yu(Shanghai Changzheng Hospital), Jun Cai(Macau University of Science and Technology), Kangli Wang(Capital Medical University), Jie Yin(Capital Medical University), Zhigang Bai(Yale Cancer Center)
PubMed
January 1, 2015
Cited by 25

Related Papers

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade
|Cancer Discovery|2020|143
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
|Nature Immunology|2019|121
Electroacupuncture vs Sham Electroacupuncture in the Treatment of Postoperative Ileus After Laparoscopic Surgery for Colorectal Cancer
|JAMA Surgery|2022|111
Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial
|Surgical Endoscopy|2018|100